2.3980
0.0000
(0.00%)
At close: January 31 at 3:00:00 PM EST
Breakdown
6/30/2024
6/30/2023
6/30/2022
Total Assets
154,629.2070
76,896.4060
99,821.9430
Total Liabilities Net Minority Interest
8,331.7570
7,720.7380
7,585.4090
Total Equity Gross Minority Interest
146,297.4500
69,175.6680
92,236.5340
Total Capitalization
146,297.4500
69,175.6680
92,236.5340
Common Stock Equity
146,297.4500
69,175.6680
92,236.5340
Net Tangible Assets
146,297.4500
69,175.6680
92,236.5340
Working Capital
145,972.4880
69,135.8810
92,043.9230
Invested Capital
146,297.4500
69,175.6680
92,236.5340
Tangible Book Value
146,297.4500
69,175.6680
92,236.5340
Share Issued
311,645.8970
132,525.7260
258,739.8210
Ordinary Shares Number
311,645.8970
132,525.7260
258,739.8210
6/30/2022 - 8/15/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TLPPF Telix Pharmaceuticals Limited
17.99
0.00%
DTCFF Defence Therapeutics Inc.
0.7500
0.00%
TLX Telix Pharmaceuticals Limited
18.60
+1.92%
TLX.AX Telix Pharmaceuticals Limited
29.34
+1.84%
BOT.AX Botanix Pharmaceuticals Limited
0.4350
0.00%
RADX Radiopharm Theranostics Limited
4.6400
-3.93%
OCS Oculis Holding AG
22.91
+2.51%
NEU.AX Neuren Pharmaceuticals Limited
14.49
+0.28%
TVTX Travere Therapeutics, Inc.
20.46
-2.80%
RYTM Rhythm Pharmaceuticals, Inc.
59.43
+0.35%